MedPath

Prospective randomized study on non-inferiority analysis/equivalence analysis of the surgical procedures GreenLight and Rezum for benign prostatic hyperplasia (AG BPH)

Not Applicable
Recruiting
Conditions
N40
Hyperplasia of prostate
Registration Number
DRKS00034013
Lead Sponsor
Charite- Universitätsmedizin Berlin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
160
Inclusion Criteria

Capacity to consent

Exclusion Criteria

younger 18, female

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
REZUM demonstrates non-inferiority in subvesical deobstruction compared to GreenLight for <80cc prostates.<br>Difference in IPSS + QoL (pre-operative to 30 days post-operative).<br>Difference in IPSS + QoL (pre-operative to 1 year post-operative).
Secondary Outcome Measures
NameTimeMethod
REZUM demonstrates non-inferiority in subvesical deobstruction compared to GreenLight for >80cc prostates.<br><br>Retrograde Ejaculation<br>Recurrence of urinary retention (on XXth post-operative day)<br>Successful catheter removal (on XXth post-operative day)<br>Clavien-Dindo III-V (clinically relevant)<br>Recurrent infections<br>Surgical duration (to be differentiated in the table)<br>Discharge (on XXth post-operative day)
© Copyright 2025. All Rights Reserved by MedPath